On 19 June 2019, the Tripartite – a joint effort by the Food and Agriculture Organization (FAO), the World Organisation for Animal Health (OIE) and the World Health Organization (WHO) – launched the Antimicrobial Resistance (AMR) Multi-Partner Trust Fund.
The AMR Trust Fund, which is being supported by an initial contribution of US$ 5 million from the Government of the Netherlands, has a five-year scope, through 2024, and aims to scale up efforts to support countries to counter the immediate threat of AMR, arguably the most complex threat to global health.
The immediate funding appeal is for US$ 70 million, to be used to support countries and the implementation of the Tripartite’s AMR Workplan 2019–2020, particularly in providing technical support to countries designing National Action Plans on AMR and to scale up local action.
Prominent among the AMR Trust Fund’s ultimate desired outcomes is a world where infectious diseases can continue to be treated with effective and safe antimicrobials and one in which resistance is monitored and controlled at a slower pace. The pathway to that success entails activities ranging from awareness raising and the drafting of national action plans to surveillance of AMR trends and better ensuring responsible antimicrobial sales and use patterns.
The AMR Trust Fund provides a joint mechanism for clear attribution and transparency of all sources of finance, while its activities will be based on the application of best practices, scaling up activities that have worked and innovative approaches to ensure that today’s cures are available for future generations.
The UN Multi-Partner Trust Fund Office, the UN centre of expertise in pooled funding mechanisms, will act as trustee of the Fund. It will provide real-time information on contributions and use of resources of donor contributions through the Multi-Partner Trust Fund Office Gateway.